Prone ventilation in ards: What does evidence Say
International Journal of Development Research
Prone ventilation in ards: What does evidence Say
Received 19th June 2020; Received in revised form 13th July 2020; Accepted 06th August 2020; Published online 23rd September 2020
Copyright © 2020, Umesh Kumar Bylappa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Prone position ventilation (PP) has been used since the 1970s to treat severe hypoxemia in patients with ARDS/ALI because of its effectiveness at improving gas exchange.Meta-analyses have suggested better survival in patients with an arterial oxygen tension (PaO2)/inspiratory oxygen fraction (FIO2) ratio, 100 mmHg. A recent randomized controlled PROSEVA study trial was performed in ARDS patients in 2013 after a stabilization period of 12–24 h and severity criteria (PaO2/FIO2-150 mmHg at a positive end-expiratory pressure >5 cmH2O). This randomized control study showed a significant reduction in mortality in prone group 32.8% versus in supine group 16% (P-0.001). The main goal of this article are to discuss about prone position ventilation which improves oxygenation in patients with ALI/ARDS; the evidence of its use based on trial analysis; and the limitations of its use as well as the current place of pronepositioning in the management of patients with ALI/ARDS. Since 2013 after proseva study trial proning has become more common in our ICUs. Although best clinical judgment to follow the PROSEVA trial’s protocol as a guideline are used and remains inconsistency in the timing and duration of proning in ARDS patients.